Oral iron supplements

American Pharmacy

Volumn 34, Issue 3, 1994, Pages 66-71

  Hansen, C M ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERATAB; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; FUMASORB; UNCLASSIFIED DRUG; IRON;

ABDOMINAL PAIN; ANEMIA; CONSTIPATION; DIARRHEA; HUMAN; IRON DEFICIENCY; NAUSEA; ORAL DRUG ADMINISTRATION; SHORT SURVEY; VOMITING; ARTICLE; DRUG INTERACTION; FEMALE; INTESTINE ABSORPTION; IRON DEFICIENCY ANEMIA; MALE; NUTRITIONAL REQUIREMENT; QUESTIONNAIRE;

ADMINISTRATION, ORAL; ANEMIA, HYPOCHROMIC; DRUG INTERACTIONS; FEMALE; HUMAN; INTESTINAL ABSORPTION; IRON; MALE; NUTRITIONAL REQUIREMENTS; QUESTIONNAIRES;

EID: 0028182996     PISSN: 01603450     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0160-3450(15)30485-2     Document Type: Article

References (25)

1. P.R. Dallman Iron deficiency: diagnosis and treatment West J Med. 134 1981 496 505 June
2. C.K. Arthur J.P. Isbister Iron deficiency: misunderstood, misdiagnosed and mistreated Drugs. 33 1987 171 182
3. B. Lozoff E. Jimenez A.W. Wolf Long-term developmental outcome of infants with iron deficiency N Engl J Med. 325 1991 687 694
4. T. Walter I. DeAndraca P. Chadud Iron deficiency anemia: adverse effects on infant psychomotor development Pediatrics. 84 1989 7 17
5. R. Yip N.J. Binkin Declining prevalence of anemia among low-income children in the United States JAMA. 258 1987 1619 1623
6. F. Oski Iron deficiency in infancy and childhood N Engl J Med. 329 1991 190 193
7. S.J. Leclair Iron metabolism and hypochromic anemias D. Harmening Clinical Hematology and Fundamentals of Hemostasis 2nd ed. 1991 FA Davis, Co. Philadelphia 77 86
8. K.R. Bridges H.F. Bunn Anemias with disturbed iron metabolism J.D. Wilson E. Braunwald K.J. Isselbacher Harrison's Principles of Internal Medicine 12th ed. 1991 McGraw-Hill, Inc. New York 1518 1521
9. G.J. Bubley R.F. Lange Microcytic anemias S.H. Robinson P.R. Reich Hematology; Pathophysiologic Basis for Clinical Practice 3rd ed. 1993 Little, Brown and Co. Boston 35 47
10. Recommended Dietary Allowances 10th ed. 1989 National Academy Press Washington 195 205
11. B.R. Olin Drug Facts and Comparisons 1992 J.B. Lippincott and Co. St. Louis 62 66
12. P.R. Dallman M.A. Siimes A. Stekel Iron deficiency in infancy and childhood Am J Clin Nutr. 33 1980 86 118
13. L.V. Allen Nutritional products E.G. Feldman W.L. Blockstein L.L. Young Handbook of Nonprescription Drugs 10th ed. 1993 American Pharmaceutical Association Washington 283 311 755–7
14. G. Grebe C. Martinez-Torres M. Layrisse Effect of meals and ascorbic acid on the absorption of a therapeutic dose of iron as ferrous and ferric salts Curr Ther Res. 17 1975 382 397 April
15. C. Brock H. Curry C. Hanna Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets Clin Ther. 7 1985 568 573
16. L. Hallberg L. Ryttinger L. Solvell Side-effects of oral iron therapy: a double-blind study of different iron compounds in tablet form Acta Med Scand. 459 suppl 1966 3 10
17. L.J. Lifton J. Kreiser False-positive stool occult blood tests caused by iron preparations Gastroenterology. 83 1982 860 863
18. S.L. Gray Fecal occult blood testing for colorectal cancer Am Pharm. 32 1992 50 53 October
19. M.A. O'Neil-Cutting W.H. Crosby The effect of antacids on the absorption of simultaneously ingested iron JAMA 255 1986 1468 1470
20. J.J. Leyden Absorption of minocycline hydrochloride and tetracycline hydrochloride J Am Acad Dermatol. 12 1985 308 312
21. N. Campbell B.B. Hasinoff Iron supplements: a common cause of drug interactions Br J Clin Pharmacol. 31 1991 251 255
22. M. Kara B.B. Hasinoff D.W. McKay Clinical and chemical interactions between iron preparations and ciprofloxacin Br J Clin Pharmacol. 31 1991 257 261
23. N.R.C. Campbell B. Hasinoff Ferrous sulfate reduces levodopa bioavailability: chelation as a possible mechanism Clin Pharmacol Ther. 45 1989 220 225
24. N.R.C. Campbell D. Rankine A.B. Goodridge Sinemet-ferrous sulphate interaction in patients with Parkinson's disease Br J Clin Pharmacol. 30 1990 599 605
25. N. Campbell V. Paddock R. Sundaram Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate Clin Pharmacol Ther. 43 1988 381 386